NeuraLight is a digital health company advancing neurological evaluation and care. Our AI-driven platform integrates objective and sensitive digital markers to improve drug development, monitoring, and precision care for patients with neurological disorders – focusing on AD, PD, ALS, and MS.
Our platform includes proprietary Deep Learning algorithms that automatically extract a host of digital oculometric markers from facial videos captured on a standard webcam or smartphone. We are supported by a Scientific Advisory Board, including two Nobel Laureates, and have raised over $30M to date.